For example, tumor cells can express immune checkpoint modulators like cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death ligand 1 (PD-L1), which act to suppress the immune response. Here, CTLA4 is linked to neoplasm.